Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02117297
Title SCT Plus Immune Therapy in Average Risk AML/MDS
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York Medical College
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
New York Medical College Valhalla New York 10595 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field